About Us
Our Story
Team
Careers
News
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Select specialty
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Oncology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Primary Care
Psychiatry
Pulmonology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Confirm Password
Mohs Surgery for Melanoma - Techniques and Timing of Treatment
By
Melanoma 2019: 29th Annual Cutaneous Malignancy Update
FEATURING
Adam Sutton
February 7, 2019
0 Comments
Login to view comments.
Click here to Login
Related Content
AUTOPLAY
ON
21:50
Melanoma 2020: 30th Annual Cutaneous Malignancy Update
Pathology of Melanoma: Overview of Morphologic Subtypes, Staging & Repor...
Feat.
C. S. Humberson
21:53
8th International Congress on Cancer Metastasis
Should a Completion Lymph Node Dissection Be Done Following a Positive M...
Feat.
M. Ross
19:20
Melanoma 2019: 29th Annual Cutaneous Malignancy Update
Pathology of Melanoma: Current Status and Prognostic Indicators
Feat.
D. Barnette
20:31
Cleveland Clinic Taussig Cancer Institute
Update in Molecular Diagnostics for Melanoma Cutaneous Malignancies
Feat.
S. Billings
12:20
Melanoma 2019: 29th Annual Cutaneous Malignancy Update
Do Dysplastic Nevi Progress to Melanoma?
Feat.
B. Kelley
12:59
Melanoma 2019: 29th Annual Cutaneous Malignancy Update
Melanoma, the Primary Lesion: Biopsy, Excision and Mohs Surgery in Selec...
Feat.
A. Sutton
22:33
Melanoma 2019: 29th Annual Cutaneous Malignancy Update
Melanoma: Head and Neck Melanoma Workup, Review of SEER Melanoma Margin ...
Feat.
C. Bergeron
20:33
Melanoma 2019: 29th Annual Cutaneous Malignancy Update
Molecular Diagnostics for Melanoma: Prognosis (PCR, FISH, Gene Expressio...
Feat.
G. Hosler
16:47
Sapna Patel
Adjuvant vs. Neoadjuvant Pembrolizumab in Melanoma: Can Neoadjuvant Immu...
16:37
Jeff Gershenwald
What’s New in the 8th Edition AJCC Melanoma Staging System
19:43
8th International Congress on Cancer Metastasis
Overview of Neoadjuvant Therapy Options for Regionally Localized or Rese...
Feat.
G. Karakousis
12:46
KU Hematology & Medical Oncology Review 2019
KU ASCO 2019 Update on Surgical Treatment of Melanoma & Adjuvant Ipilimu...
Feat.
G. Doolittle
19:16
Melanoma 2019: 29th Annual Cutaneous Malignancy Update
Moles and Melanoma in Childhood Congenital Melanocytic Nevi and Spitz Nevi
Feat.
M. Dohil
15:50
Luca Gerosa
Single-Cell ERK Signalling Dynamics Drive Adaptive Drug Resistance of BR...
08:58
Melanoma 2020: 30th Annual Cutaneous Malignancy Update
New Tools for Melanoma Prognosis: Gene Expression Profiling & Identifica...
Feat.
K. Murphy
14:19
Melanoma 2019: 29th Annual Cutaneous Malignancy Update
Molecular Profiling of a Rare Primary Leptomeningeal Melanoma
Feat.
S. Fortin Ensign
08:06
Melanoma 2020: 30th Annual Cutaneous Malignancy Update
82 y/o Male With Malignant Melanoma: SLNB in + Amputation, Candidate for...
Feat.
M. Seago
11:46
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020
Medications and Microbiome: Antibiotics Associated With Worse Outcomes, ...
Feat.
J. McQuade
10:33
Melanoma 2020: 30th Annual Cutaneous Malignancy Update
84 y/o Male Referred to Bighorn Mohs for Melanoma: Oncologic Management ...
Feat.
M. Seago
18:43
Melanoma 2020: 30th Annual Cutaneous Malignancy Update
New Tools for Melanoma Diagnosis: Gene Expression Profiling, Chromosome ...
Feat.
K. Murphy
